Pulmonary embolism (PE)

Diagnostic and therapeutic approach

  1. Diagnosis
  2. Scores
  3. Treatment
  4. Pharmaceuticals
  5. ESC recommandations

Pharmaceuticals

  1. Apixaban (Eliquis)
  2. Dabigatran (Pradaxa)
  3. Enoxaparin (Clexane)
  4. Fondaparinus (Arixtra)
  5. RtPA (Actilyse)
  6. Urokinase
  7. Rivaroxaban (Xarelto)
  8. Edoxaban (Lixiana)
  9. Anticoagulants

Apixaban (Eliquis)

(Eliquis)

Dosage

10mg 2x/day during 7 days, then 5mg 2x/day.

Contra-indications

  • Hypersensitivity to the active substance or to any of the excipients.
  • Clinically significant active bleeding.
  • Liver diseases associated with coagulopathy and clinically relevant bleeding risk with severe hepatic impairment (Child Pugh C).
  • Attention to drug interactions and inhibitors of CYP3A4 and / or P-gp.

http://www.drugs.com/eliquis.html